HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners
Content not available.
Content not available.
免责声明: 资讯内容来源于监管机构及第三方出版物。MedPath 不对其准确性作出保证。本信息仅供参考，不构成医疗建议。